LINK: https://us06web.zoom.us/j/85099759729?pwd=Y3GSQZXQX1H0wgxXL7YZZu2mP8pozW.1&from=addo

OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Describe the TEP approved five recommendations for spasticity management within the article, (2) Identify the five best practices for assessment and management of spasticity and analyze the one recommendation unable to be graded due to evidence limitations, (3) Review the consensus guidance statement represents current best practices and evidence-based treatment options, discuss the intended for use by PM&R physicians within their practices (Verduzco-Gutierrez MD, et al., 2024); (4) Evaluate key differences between Medicare Fee-for-service and Medicare Advantage models, (5) Identify drivers of disparities that exist in access to quality rehabilitation care in the U.S, (6) Define the term "dual-eligible beneficiaries" (Karmarkar et al., 2026).

FACULTY DISCLOSURE: Dr. Mason Tincher and Dr. Lauren McCormack have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: The planners have no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

*Recording of this educational activity, including the use of AI tools, is prohibited.

For information, please contact Alina Manjiyani at [email protected]